Home » Authors » James Etheridge

Articles by James Etheridge

IDM Acquires Cancer Assets For Stock In Deal With Jenner

April 16, 2003

By James Etheridge

NicOx Panel Finds Violations Of Protocol In AZD3582 Trial

April 2, 2003

By James Etheridge

Neurotech Enters Ophthalmology Research Alliance With INSERM

April 2, 2003

By James Etheridge

NicOx Panel Finds Violations Of Protocol In AZD3582 Trial

April 2, 2003

By James Etheridge

Neurotech Enters Ophthalmology Research Alliance With INSERM

April 2, 2003

By James Etheridge

Genopole Now Boasts 42 Biotech Companies And 23 Laboratories

March 26, 2003

By James Etheridge

Serono Demonstrates Efficacy Of Raptiva Over The Long Term

March 26, 2003

By James Etheridge

Genopole Now Boasts 42 Biotech Companies And 23 Laboratories

March 26, 2003

By James Etheridge

Serono Demonstrates Efficacy Of Raptiva Over The Long Term

March 26, 2003

By James Etheridge

Entomed, Naeja Enter Two-Way Cancer, Infectious Diseases Deal

March 19, 2003

By James Etheridge

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...